Boehringer Ingelheim invests $75,000 in PRRS research
US - Research into PRRSV (Porcine Reproductive and Respiratory Syndrome virus) got a $75,000 boost from Boehringer Ingelheim this month. Three studies have each received grants of $25,000 through the company's PRRS Research Award program.
19 March 2004
2 minute read
